
During recent years, cancer vaccines have made encouraging progress toward becoming a clinically relevant form of zzso zzso However, current vaccine approaches have shown only limited success in patients with cancer because of inadequate immune zzso Recent insights into the elements that regulate immune responsiveness have provided new opportunities to enhance the efficacy of cancer vaccines through multiple pathways that involve zzso and zzso arms of the immune zzso This article presents a set of emerging strategies that have resulted from our recent efforts to boost zzso zzso immunity and improve patient zzso These new insights represent important consideration for the design and development of more effective zzso during the next zzso 

